UPLOAD Filing
IO Biotech, Inc.
Date: July 29, 2025 · CIK: 0001865494 · Accession: 0000000000-25-007962
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288936
Letter
Re: IO Biotech, Inc. Registration Statement on Form S-3 Filed July 24, 2025 File No. 333-288936 Dear Mai-Britt Zocca:
July 29, 2025
Mai-Britt Zocca President and Chief Executive Officer IO Biotech, Inc. Ole Maal es Vej 3 DK-2200 Copenhagen N Denmark
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Istvan A. Hajdu, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 29, 2025 Mai-Britt Zocca President and Chief Executive Officer IO Biotech, Inc. Ole Maal es Vej 3 DK-2200 Copenhagen N Denmark Re: IO Biotech, Inc. Registration Statement on Form S-3 Filed July 24, 2025 File No. 333-288936 Dear Mai-Britt Zocca: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Istvan A. Hajdu, Esq. </TEXT> </DOCUMENT>